Предыдущая страница реферата | 1  2  3  4  5  6  7  8 | Следующая страница реферата

Maugendre D., Gatel A., Campion L., et al. Antithyroid drugs and Graves' disease — prospective randomised assessment of long-term treatment. // Clin Endocrinol — 1999 — Vol. 50. — P. 127-132.

Hashizume K., Ichikawa K., Sakurai A., et al. Administration of thyroxine in treated Graves' disease: Effects on the level of antibodies to thyroid stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. // N Engl J Med — 1991 — Vol. 324. — P. 947-953.

Rittmaster R.S., Abbot E.C., Douglas R., et al. Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. // J Clin Endocrinol Metab — 1998 — Vol. 83. — P. 814-818.

McIver B., Rae P., Beckett G., Wilkinson E., Gold A., Toft A. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. // N Engl J Med — 1996 — Vol. 334. — P. 220-224.

Tajiri J., Noguchi S., Murakami T., Murakami N. Antithyroid druginduced agranulocytosis. The usefulness of routine white blood cell count monitoring. // Arch Int Med — 1990 — Vol. 150. — P. 621-624.

Williams K.V., Nayak S., Becker D., Reyes J., Burmeister L.A. Fifty years of experience with propylthiouracil-associated hepatotoxicity: What have we learned? // J Clin Endocrinol Metab — 1997 — Vol. 82. — P. 1727- 1733.

Sera N., Ashizawa K., Ando T., et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. // Thyroid — 2000 — Vol. 10. — P. 595-599.

Jarlov A.E., Hegedus L., Kristensen L.O., Nygaard B., Hansen J.M. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? // Clin Endocrinol — 1991 — Vol. 43. — P. 325-329.

Alexander E.K., Larsen P.R. High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease. // J Clin Endocrinol Metab — 2002 — Vol. 87. — P. 1073-1077.

Farrar J.J., Toft A.D. Iodine-131 treatment of hyperthyroidism: Current issues. // Clin Endocrinol — 1991 — Vol. 35. — P. 207-212.

Kadmon P.M., Noto R.B., Boney C.M., Goodwin G., Gruppuso P.A. Thyroid storm in a child following radioactive iodine (RAI) therapy: A consequence of RAI versus withdrawal of antithyroid medication. // J Clin Endocrinol Metab — 2001 — Vol. 86. — P. 1865-1867.

Imseis R.E., Vanmiddlesworth L., Massie J.D., Bush A.J., Vanmiddlesworth N.R. Pretreatment with propylthiouacil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. // J Clin Endocrinol Metab. — 1998 — Vol. 83. — P. 685-687.

Andrade V.A., Gross J.L., Maia L. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: One-year follow-up of a prospective, randomized study. // J Clin Endocrinol Metab. — 2001 — Vol. 86. — P. 3488-3493.

Sabri O., Zimny M., Schulz G., et al. Success rate of radioiodine therapy in Graves' disease: The influence of thyrostatic medication. // J Clin Endocrinol Metab — 1999 — Vol. 84. — P. 1229-1233.

Bartalena L., Marcocci C., Bogazzi F., et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. // N Engl J Med — 1998 — Vol. 338. — P. 73-78.

Weetman A.P., Wiersinga W.M. Current management of thyroidassociated ophthalmopathy in Europe: Results of an international survey. // Clin Endocrinol — 1998 — Vol. 49. — P. 21-28.

Ron E., Doody M.M., Becker D.V., et al. Cancer mortality following treatment for adult hyperthyroidism. // JAMA — 1998 — Vol. 280. — P. 347 — 355.

Franklyn J.A., Maisonneuve P., Sheppard M.C., Betteridge J., Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study. // Lancet — 1999 — Vol. 353 — P. 2111 — 2115.

Werga-Kjellman P., Zedenius J., Tallstedt L., Traisk F., Lundell G., Wallin G. Surgical treatment of hyperthyroidism: A ten-year experience. // Thyroid 2001 — Vol. 11. — P. 187-192.

Mandel S.J., Cooper D.S. The use of antithyroid drugs in pregnancy and lactation. // J Clin Endocrinol Metab — 2001 — Vol. 86. — P. 2354 — 2359.

Karlsson F.A., Axelsson O., Melhus H. Severe embryopathy and exposure to methimazole in early pregnancy. // J Clin Endocrinol Metab — 2002 — Vol. 87. — P. 947-948.

Smith C., Thomsett M., Choong C., Rodda C., McIntyre H.D., Cotterill A.M. Congenital thyrotoxicosis in premature infants. // Clin Endocrinol — 2001 — Vol. 54. — P. 371-376.

Laurberg P., Nygaard B., Glinoer D., Grussendort M., Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: Results of an evidence-based symposium organized by the European Thyroid Association. // Eur J Endocrinol — 1998 — Vol. 139. — P. 584-586.

Azizi F., Khoshniat M., Bahrainian M., Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. // J Clin Endocrinol Metab — 2000 — Vol. 85. — P. 3233 — 3238.

Momotani N., Yamashita R., Makino F., et al. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. // Clin Endocrinol — 2000 — Vol. 53. — P. 177-181.

Рекомендуем скачать другие рефераты по теме: шпаргалки для студентов, титульный дипломной работы.



Предыдущая страница реферата | 1  2  3  4  5  6  7  8 | Следующая страница реферата

Поделитесь этой записью или добавьте в закладки